Exalenz Bioscience named Gavin Doree the company's new vice president of sales.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- ILa | -.--% | +1.39% | +107.88% |
1st Jan change | Capi. | |
---|---|---|
+107.88% | 4.6Cr | |
-2.26% | 19TCr | |
+2.05% | 11TCr | |
-1.31% | 6.95TCr | |
+14.65% | 4.64TCr | |
-6.69% | 4.6TCr | |
+7.97% | 4.25TCr | |
+18.60% | 3.07TCr | |
-6.87% | 2.33TCr | |
-10.63% | 2.29TCr |
- Stock Market
- Equities
- EXEN Stock
- News Exalenz Bioscience Ltd
- Exalenz Bioscience Appoints Gavin Doree as New Vice President of Sales